Home/Filings/4/0001273636-19-000019
4//SEC Filing

Feinsod Matthew 4

Accession 0001273636-19-000019

CIK 0001273636other

Filed

Jul 14, 8:00 PM ET

Accepted

Jul 15, 4:45 PM ET

Size

6.1 KB

Accession

0001273636-19-000019

Insider Transaction Report

Form 4
Period: 2019-07-11
Feinsod Matthew
Interim Chief Medical Officer
Transactions
  • Tax Payment

    Common Stock

    2019-07-11$3.75/sh592$2,22056,052 total
  • Award

    Common Stock

    2019-07-11+2,00056,644 total
Footnotes (1)
  • [F1]The common stock vested immediately upon grant.

Issuer

APPLIED GENETIC TECHNOLOGIES CORP

CIK 0001273636

Entity typeother

Related Parties

1
  • filerCIK 0001716950

Filing Metadata

Form type
4
Filed
Jul 14, 8:00 PM ET
Accepted
Jul 15, 4:45 PM ET
Size
6.1 KB